Previous 10 | Next 10 |
Pharmaceuticals and biotechnology are cheap relative to 11-year valuation averages. Life science tools and healthcare equipment are overvalued. IXJ: a global alternative to XLV. 10 stocks cheaper than their peers in May. For further details see: IXJ: Healthcare Dashb...
STOUGHTON, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced that management will present at the H.C. Wainwright Global Investment Conference being held at the Fontainebleau Mia...
The following slide deck was published by Collegium Pharmaceutical, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Collegium Pharmaceutical, Inc. 2022 Q1 - Results - Earnings Call Presentation
Collegium Pharmaceutical, Inc. (COLL) Q1 2022 Earnings Conference Call May 10, 2022 04:30 PM ET Company Participants Alex Dasalla - Head of IR & Corporate Communications Joe Ciaffoni - President and CEO Colleen Tupper - CFO Scott Dreyer - CCO Conference Call Participants David Amsellem - ...
Collegium Pharmaceutical press release (NASDAQ:COLL): Q1 GAAP EPS of -$0.39. Revenue of $83.75M (-4.5% Y/Y). 2022 Guidance: Total product revenues are expected in the range of $450.0 million to $465.0 million, up approximately 65% at the midpoint compared to net product revenue of $276.9...
- Generated Net Revenue of $83.8 Million - - Completed BDSI Acquisition; On Track to Exceed Targeted Run Rate Synergies of at Least $75 Million - - Resolved All Opioid-Industry Litigation - - Reaffirms 2022 Financial Guidance - - Conference Call Scheduled...
STOUGHTON, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced that the Company will host a conference call and live audio webcast on Tuesday, May 10, 2022 at 4:30 p.m. ET. The ...
Pharmaceuticals and biotechnology still are attractive regarding value and quality. Other subsectors are overvalued by 15% to 42% relative to 11-year averages. Fast facts on IBB. 10 healthcare stocks cheaper than their peers in April. For further details see: IBB: He...
Collegium Pharmaceutical Inc. (NASDAQ:COLL) traded at a new 52-week high today of $29.65. Approximately 37.9 million shares have changed hands today, as compared to an average 30-day volume of 353,000 shares. Over the past year, Collegium Pharmaceutical Inc. has traded in a range of $7.3...
STOUGHTON, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced that management will participate in the following investor conference: 21 st Annual Needham Vi...
News, Short Squeeze, Breakout and More Instantly...
Collegium Pharmaceutical Inc. Company Name:
COLL Stock Symbol:
NASDAQ Market:
Collegium Pharmaceutical Inc. Website:
2024-07-20 16:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-10 14:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...